<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The constitutional chromosomal deletion within the short arm of one copy of chromosome 11, at band p13, which often correlated with <z:e sem="disease" ids="C0206115" disease_type="Disease or Syndrome" abbrv="WAGRO">WAGR syndrome</z:e> consisting of <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> with <z:hpo ids='HP_0000526'>aniridia</z:hpo>, genitourinary malformation, and <z:hpo ids='HP_0001249'>mental retardation</z:hpo>, provided the first clue to the genetic events in the development of <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>WT1 gene is encoded by 10 exons, resulting in <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> subject to a complex pattern of alternative splicing </plain></SENT>
<SENT sid="2" pm="."><plain>WT1 gene encodes a zinc finger transcription factor, which binds to GC-rich sequences and functions as a transcriptional activator or repressor for many growth factor genes </plain></SENT>
<SENT sid="3" pm="."><plain>WT 1 protein is mainly expressed in developing kidney, testis, and ovary, indicating that it is involved in the differentiation of genitourinary tissues, <z:hpo ids='HP_0000001'>all</z:hpo> thought to be the sites of origin of <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The point mutation of WT1 results in <z:e sem="disease" ids="C0950121" disease_type="Disease or Syndrome" abbrv="">Denys-Drash syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The other <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> gene, WT2 at 11p15.5, is linked to <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The possibility that WT1 is involved in the etiology of <z:e sem="disease" ids="C0854917" disease_type="Neoplastic Process" abbrv="MRTK">rhabdoid tumor of the kidney</z:e> was discussed </plain></SENT>
<SENT sid="7" pm="."><plain>WT1 is expressed in immortalized hematologic cells such as EBV-LCL and <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e>, but not in PBL or IL-2L </plain></SENT>
<SENT sid="8" pm="."><plain>High level WT1 expression in <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells and a poor prognosis are linked in patients with <z:hpo ids='HP_0001909'>leukemia</z:hpo>, making the gene a novel marker for <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells </plain></SENT>
<SENT sid="9" pm="."><plain>A correlated expression between WT1 and mdr-1 in <z:chebi fb="0" ids="28445">vincristine</z:chebi> resistant cells indicates a close relation with multi-drug resistance and is a promising diagnostic marker for chemoresistance in <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> </plain></SENT>
</text></document>